Abstract:Antibiotic resistance is a critical global health concern, causing millions of prolonged bacterial infections every year and straining our healthcare systems. Novel antibiotic strategies are essential to combating this health crisis and bacterial non-coding RNAs are promising targets for new antibiotics. In particular, a class of bacterial non-coding RNAs called riboswitches has attracted significant interest as antibiotic targets. Riboswitches reside in the 5′-untranslated region of an mRNA transcript and tune gene expression levels in cis by binding to a small-molecule ligand. Riboswitches often control expression of essential genes for bacterial survival, making riboswitch inhibitors an exciting prospect for new antibacterials. Synthetic ligand mimics have predominated the search for new riboswitch inhibitors, which are designed based on static structures of a riboswitch's ligand-sensing aptamer domain or identified by screening a small-molecule library. However, many small-molecule inhibitors that bind an isolated riboswitch aptamer domain with high affinity in vitro lack potency in vivo. Importantly, riboswitches fold and respond to the ligand during active transcription in vivo. This co-transcriptional folding is often not considered during inhibitor design, and may explain the discrepancy between a low Kd in vitro and poor inhibition in vivo. In this review, we cover advances in riboswitch co-transcriptional folding and illustrate how intermediate structures can be targeted by antisense oligonucleotides—an exciting new strategy for riboswitch inhibitor design.

Small-Molecule Aptamer for Regulating RNA Functions in Mammalian Cells and Animals

Optimization of Exon-Skipping Riboswitches and Their Applications to Control Mammalian Cell Fate

Synthetic biology tools to promote the folding and function of RNA aptamers in mammalian cells

Small-molecule-based regulation of RNA-delivered circuits in mammalian cells

Aptamers, Riboswitches, and Ribozymes in S. cerevisiae Synthetic Biology

Rational Design of Aptazyme Riboswitches for Efficient Control of Gene Expression in Mammalian Cells

Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression

Orthogonal Protein-Responsive mRNA Switches for Mammalian Synthetic Biology

Split RNA switch: Programmable and precise control of gene expression by ensemble of pre- and post-translational regulation

Heterobifunctional small molecules to modulate RNA function

Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence.

Aptamers for allosteric regulation

Aptamer-based Regulation of Transcription Circuits

Self-feedback loop-containing synthetic mRNA switches for controlled microRNA sensing

A Computational Approach for Designing Synthetic Riboswitches for Next-Generation RNA Therapeutics

Synergetic regulation of translational reading-frame switch by ligand-responsive RNAs in mammalian cells

Opportunities for Riboswitch Inhibition by Targeting Co-Transcriptional RNA Folding Events

Recent Advances in Rna Riboswitch

Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids

Engineering ligand-responsive gene-control elements: lessons learned from natural riboswitches